Search results
King Charles cancer diagnosis: The history of illnesses in the Royal Family
The Independent via Yahoo News· 3 days agoIn February, King Charles shared he had been diagnosed with cancer following treatment for a benign...
... Results from Clinical Certification Study REMOVE with CATUVAB(R) to Enable Autologous Blood...
Digital Journal· 7 days agoCATUVAB ® is designed to reliably remove cells from EpCAM (epithelial cell adhesion molecule)-positive tumors from the blood of cancer patients. EpCAM is ...
Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Medscape· 5 days agoIs the FDA Pressing Pause on More Cancer Trials? In October, the US Food and Drug Administration...
MD Anderson Research Highlights for April 24, 2024
Newswise· 5 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Nanobiotix S.A. to Post FY2025 Earnings of $1.07 Per Share, Leerink Partnrs Forecasts (NASDAQ:NBTX)
ETF DAILY NEWS· 9 hours agoNanobiotix S.A. (NASDAQ:NBTX – Free Report) – Leerink Partnrs raised their FY2025 earnings per share (EPS) estimates for Nanobiotix in a research note issued on Thursday, April 25th. Leerink ...
Mercy BioAnalytics to Present Results from a Large Ovarian Cancer Screening Study at the ASCO Annual...
WTNH-TV New Haven· 5 days agoMercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical ...
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
Morningstar· 4 days agoCandel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight ...
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 days agoFusion (FUSN) is expected to provide updates regarding the developmental program of its lead...
Novartis bags paediatric FDA label expansion for Lutathera
Pharmaceutical Technology via Yahoo Finance· 5 days agoFusion’s lead candidate, FPI-2265 is a radioconjugate that targets prostate-specific membrane...
BioNTech (BNTX) to Release Earnings on Monday
ETF DAILY NEWS· 9 hours agoBioNTech (NASDAQ:BNTX – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Monday, May 6th. Analysts expect BioNTech to post earnings of ($0.45 ...